Know Cancer

or
forgot password

Multicentered Observational Prospective Cohort Study on the Treatment of Metastatic Colorectal Cancer and the Role of Evaluating K-Ras


Phase 2
18 Years
N/A
Open (Enrolling)
Both
Metastatic Colorectal Cancer

Thank you

Trial Information

Multicentered Observational Prospective Cohort Study on the Treatment of Metastatic Colorectal Cancer and the Role of Evaluating K-Ras


Inclusion Criteria:



- Histologic diagnosis colorectal carcinoma

- Metastatic disease

- Signed informed consent

Exclusion Criteria:

- Prior treatment of metastatic colorectal cancer

- Refusal or incapability of providing informed consent

Type of Study:

Observational

Study Design:

Observational Model: Cohort, Time Perspective: Prospective

Outcome Measure:

percentage of patients enrolled in a clinical trial

Outcome Time Frame:

two years

Safety Issue:

No

Principal Investigator

R. V. Iaffaioli, M.D.

Investigator Role:

Principal Investigator

Investigator Affiliation:

National Cancer Institute, Naples

Authority:

Italy: Ethics Committee

Study ID:

CALLAS

NCT ID:

NCT01651013

Start Date:

October 2010

Completion Date:

October 2015

Related Keywords:

  • Metastatic Colorectal Cancer
  • Colorectal Neoplasms

Name

Location